Acute myeloid leukemia cells are targeted by the naturally occurring CXCR4 antagonist EPI-X4
L. M. Kaiser, M. Harms, D. Sauter, V. P. S. Rawat, M. Glitscher, R. Gross, E. Hildt, J. Muench, C. Buske
Abstract
This manuscript has been withdrawn by the authors as no consent could be achieved with regard to data contribution. Based on this no agreement on authorship and/or listing in the acknowledgement section was reached. Therefore, the authors do not wish this work to be cited as reference for the project. If you have any questions, please contact the corresponding author.
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- CXCR4 signaling is counteracted by the naturally occurring CXCR4 antagonist EPI-X 4 in Waldenstrom Macroglobulinemia
L. M. Kaiser, M. Harms, … C. Buske·bioRxiv·Oct 19, 2020
- CXCL12 chemokine dimer signaling modulates acute myelogenous leukemia cell migration through altered receptor internalization
Donovan Drouillard, Michael Halyko, … Michael B. Dwinell·Scientific ReportsPeer-reviewed·Jul 22, 2025
- A novel in-vitro model of the bone marrow microenvironment in AML identifies CD44 and Focal Adhesion Kinase as therapeutic targets to reverse cell adhesion-mediated drug resistance
Eleni E Ladikou, K. Sharp, … Andrea G. S. Pepper·CancersPeer-reviewed·Jan 3, 2025
- Biomolecular models of EPI-X4 binding to CXCR4 allow the rational optimization of peptides with therapeutic potential
Pandian Sokkar, Mirja Harms, … Elsa Sánchez‐García·bioRxiv·Oct 23, 2020
- CCL19, not CCL21 induces CCR7-mediated stimulation of leukemia apoptosis by targeting endosomal signaling signaling
- CXCR4 signaling strength regulates hematopoietic multipotent progenitor fate through extrinsic and intrinsic mechanisms
V. Rondeau, M. Kalogeraki, … K. Balabanian·bioRxiv·May 31, 2023